COMPANY
Takeda Pharmaceuticals International AG
Takeda Pharmaceuticals International AG: marketing authorisation holder for Icatibant, Teduglutide, as stated by public registers.
Also written as: TAKEDA PHARMACEUTICALS INTERNATIONAL AG.
MARKETING AUTHORISATION HOLDER
Holds the licence to sell the medicine in a country (EMA, MHRA, Health Canada).
| Icatibant | Firazyr (EMEA/H/C/000899), Authorised Regulator EMA |
|---|---|
| Icatibant | FIRAZYR 30 MG SOLUTION FOR INJECTION IN PRE FILLED SYRINGE, PLGB 54937/0004, Authorised Regulator MHRA |
| Teduglutide | REVESTIVE 1.25 MG POWDER AND SOLVENT FOR SOLUTION FOR INJECTION, PLGB 54937/0015, Authorised Regulator MHRA |
| Teduglutide | REVESTIVE 5 MG POWDER AND SOLVENT FOR SOLUTION FOR INJECTION, PLGB 54937/0016, Authorised Regulator MHRA |
What a register states, not an endorsement or an accusation by this site. All companies.
WEEKLY
Register Watch, weekly
New trials, approvals and enforcement actions. One email a week.